Cellomics confers with European customers
PITTSBURGH, June 27, 2006— More than 60 customers shared their experiences with high content screening and analysis and provided insight for development of new tools during Cellomics’ second annual European User Group meeting held recently at Trinity College in Dublin.
Cellomics, the creator of and world leader in high content screening (HCS) and a unit of Fisher Biosciences, sponsors annual user group meetings in both the United States and Europe. The meetings bring together scientists from pharmaceutical and biotechnology companies as well as key academic institutions to address productive uses of high content analysis applications and technologies, which are playing an increasing role in cell biology research and drug discovery.
“These conferences are an ideal forum for us to interact with our customers,” said Dan Calvo, president and chief executive officer of Cellomics. “They facilitate discussion of usability improvements, provide direction for new product development and foster networking among our customers.”
The meeting at Trinity College, which is a Cellomics customer, took place June 7-8. The agenda included an update on Cellomics’ expansion in Europe; an overview of new products; scientific presentations by customers, who briefed attendees on their own use of HCS; an introduction to complementary technologies offered by Fisher Biosciences, including recently acquired BioImage; and a facilitated Q&A concerning Cellomics technologies. In addition, there was an overview of two new technologies: the Neuronal Profiling BioApplicaton, which is an image analysis module for studying neurite outgrowth and different types of measurements associated with neuronal biology; and the VTI Live module, which is a complete live cell chamber and kinetic software for Cellomics’ ArrayScanŇ VTI HCS Readers.
“Our employees and customers represent the largest pool of high content screening and analysis knowledge available,” said Calvo. “The Dublin conference allowed us to share this knowledge and perpetuate the successful use of HCS technology, while simultaneously helping us to better meet the needs of our customers by providing insight into their future requirements.”
Trinity College has approximately 40 scientists using high content screening technology, and the number is growing, according to Dr. Anthony Davies, high content analysis research facility manager at Trinity’s Institute of Molecular Medicine. The College has also developed a master’s course in high content screening, with the participation of specialists from research institutions and companies like Cellomics that are leaders in high-content analysis technology. Davies said that the recent Cellomics user group meeting was very useful to the college.
“We have a diversity of scientific projects ongoing in areas such as cancer, inflammation, nanotechnology, infection and immunity,” said Davies. “The meeting here at Trinity provided us with an excellent opportunity to discuss our work with Cellomics and to benefit from the company’s extensive scientific expertise. We were very excited to host the European User Group meeting, and we look forward to further collaboration with Cellomics with our newly developed master’s program.”
Cellomics, a business unit within the Fisher Biosciences group, provides complete systems for High Content Screening (HCS) and Analysis (HCA) to drug discovery and systems biology researchers. The Cellomics platform includes automated imaging instrumentation (ArrayScan® and KineticScan® HCS Readers and the cellWoRxTM High Content Cell Analysis System), BioApplication image analysis software, High Content Informatics (HCiTM ), and HitKit® HCS Reagent Kits, fully integrated to improve the quality and productivity of cell-based assays. Cellomics’ proprietary platforms are in use at multiple sites within the top 15 pharmaceutical companies, as well as leading biotechnology companies and academic centers throughout the world. For more information about Cellomics-brand products and services, please visit www.cellomics.com or call 412-770-2200.
About Fisher Biosciences
Fisher Biosciences, a unit of Fisher Scientific International Inc., manufactures and supplies a wide range of products and services across the general-chemistry and life-sciences arenas. From fine and high-purity chemicals, clinical diagnostics, proprietary protein-research and cell-culture products, and sterile-liquid-handling systems, to innovative RNA-interference technology and high content screening, Fisher Biosciences serves scientific-research, healthcare, drug-discovery, and general industrial customers around the world. Additional information about Fisher Biosciences is available online at www.fisherbiosci.com.
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.